Watch SPTX. Know when insiders buy.
One email the day a filing lands. Free.
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2026 · Sep 30 | — | — | — | −$30.3M | −$26.4M | — | -0.49 | −$22.7M | $0 | −$22.7M | Nov 2 |
| Q2 2026 · Jun 30 | — | — | — | −$65.8M | −$62.6M | — | -1.78 | −$26.1M | $0 | −$26.1M | Nov 2 |
| Q1 2026 · Mar 31 | — | — | — | −$27.5M | −$25.4M | — | -10.34 | −$20.2M | $0 | −$20.2M | Nov 2 |
| Q3 2025 · Sep 30 | — | — | — | −$25.4M | −$22.5M | — | -9.43 | −$15.8M | $8K | −$15.8M | Nov 2 |
| Q2 2025 · Jun 30 | — | — | — | −$18.5M | −$15.1M | — | -6.40 | −$15.3M | $269K | −$15.6M | Nov 2 |
| Q1 2025 · Mar 31 | — | — | — | −$16.2M | −$13.1M | — | -5.65 | −$20.2M | $54K | −$20.3M | Nov 2 |
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|
Every number comes from Seaport Therapeutics, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.